Anavex Life Sciences Corp (AVXL)

[JB3729]

The high share price in 2008 was probably due to the Patrick Cox newsletter. The O/S was miniscule at that time.

From 2008 up until 2013, Anavex's CEOs were unable to raise funds to advance A2-73. Alzheimer's Disease drugs had a miserable history of failure and Anavex's CEOs were not well connected.

Dr. Missling became CEO in mid 2013. Anavex announced that they had raised funds at he same time.
http://www.anavex.com/?news=anavex-raises-2-6-million-in-private-placement-and-conversion-of-liabilities-enters-into-10-million-financing-commitment-and-appoints-ceo

Dr. Missling discussed the challenge of raising money here -
http://lifescienceleadermag.epubxp.com/i/547536-aug-2015/47

Anavex reported the first data from their Phase 2a trial in July, 2015. This was followed by the 1/4 RS and Nasdaq up listing. The price went up to nearly $15.

Then the hit pieces from Street Sweeper, SA, Adam F, and others tanked the price to $3.20.

The price recovered to $8 before news of an SEC subpoena and class action law suits. Anavex countered that they believed the subpoena had to do with the volatile trading and the belief that the lawsuits were without merit. Regardless, the price dropped to $3.30.

The price has recovered somewhat and now we are awaiting data again.

Very good entry point, IMO.